Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

NCT05827549

Conditions
Acute Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Chonnam National University Hwasun Hospital Hwasun, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Recruiting

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

NCT05541341

Conditions
Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +16 more
Locations
  • Novartis Investigative Site Minas Gerais, Belo Horizonte, Brazil
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site São Paulo, Brazil
View Trial Details
Recruiting

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

NCT06793410

Conditions
Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
Locations
  • Skåne's University Hospital Lund, Region Skåne, Sweden
  • Karolinska University Hospital Stockholm, Region Stockholm, Sweden
  • Uppsala University Hospital Uppsala, Region Uppsala, Sweden
  • Linköping University Hospital Linköping, Region Östergötaland, Sweden
View Trial Details
Recruiting

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

NCT03104491

Conditions
Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

NCT06414148

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

NCT06547528

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Akita University Hospital Akita, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 14 locations
View Trial Details

Related conditions